Is Vonoprazan available in China?

Vonoprazan(Vonoprazan)has been launched in China. In February 2015, Vonoprazan was first launched in Japan for the treatment of acid-related diseases and as an auxiliary drug for the eradication of Helicobacter pylori (H. pylori). In May 2022, the FDA approved the use of vonoprazan in co-packaged products containing amoxicillin and clarithromycin to treat Helicobacter pylori infection. Studies have shown that the combined use of vonoprazan, amoxicillin, and clarithromycin results in an H. pylori eradication rate of approximately 90%. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.